Befiradol was discovered and developed by Pierre Fabre Médicament, a French pharmaceuticals company.It is an experimental drug being studied for the treatment of levodopa-induced dyskinesia. Reference standards of Befiradol API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Befiradol - API Standards [catalogue_number] => PA 02 98000 [category_ids] => ,79,80,89, [chemical_name] => [weight] => 393.86 [form] => C20H22ClF2N3O [cas] => 208110-64-9 [pslug] => 208110-64-9-befiradol-api-pa0298000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 98000
CAS :
Molecular Formula : C20H22ClF2N3O
Molecular Weight : 393.86
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
